Microscopic Revelations Point to New Blood Infection Therapies

Researchers at the University of Calgary’s Cumming School of Medicine have, for the first time, been able to observe – live and in real-time – how the human body responds to often lethal fungal blood infections in the lung. In the study, the fungal infection Candida albicans was introduced to mice or human models of [...]

By |2018-12-19T11:56:34+00:00December 19th, 2018|Regional News|0 Comments

CAR T-Cell Therapy Recommended for Cases of Some Types of Non-Hodgkin Lymphoma

NICE has published final draft guidance recommending a breakthrough cancer treatment, called CAR T-cell therapy, for adults with certain types of non-Hodgkin lymphoma. Axicabtagene-ciloleucel, also known as Yescarta and manufactured by Kite, a Gilead company, is part of a new wave of personalised medicine. The therapy is for adults with relapsed or refractory diffuse large [...]

By |2018-12-19T11:55:17+00:00December 19th, 2018|Regional News|0 Comments

Scientists Discover a New Route to Antibiotics Using Gene Editing

Scientists have discovered a new chemical process – also known as a biosynthetic pathway – in bacteria which could lead to a new generation of antibiotics being produced and manufactured. Researchers at The University of Manchester’s School of Chemistry have said that their new pathway includes an enzyme, called a carboxylase, which adds CO2 to [...]

By |2018-12-12T09:40:56+00:00December 12th, 2018|Regional News|0 Comments

FDA Authorises First Test to Aid in Detecting a Type of Herpes Virus in Newborns

The US Food and Drug Administration (FDA) has permitted the marketing of a new diagnostic test to aid in detecting a type of herpes virus called cytomegalovirus (CMV) in newborns less than 21 days of age. ‘Although most people who become infected with cytomegalovirus face little to no risk of serious illness, the virus has [...]

By |2018-12-12T09:20:43+00:00December 12th, 2018|Regional News|0 Comments

Low-Risk People with Diabetes May be Testing their Blood Sugar Too Often

For people with type 2 diabetes, the task of testing their blood sugar with a fingertip prick and a drop of blood on a special strip of paper becomes part of everyday life. However, a new study has suggested that some of them test more often than they need to. In fact, the research shows [...]

By |2018-12-12T09:19:29+00:00December 12th, 2018|Regional News|0 Comments

Researchers Find Promise in New Treatment for Peanut Allergy

Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine have said that an oral immunotherapy drug which they tested could be the first FDA-approved medication of its kind for people with a peanut allergy. The medication, called AR101, is derived [...]

By |2018-12-05T09:54:54+00:00December 5th, 2018|Regional News|0 Comments

Life-Extending Treatment for Patients with Advanced Liver Cancer Recommended

A life-extending treatment for some adults with advanced liver cancer has been recommended for use on the NHS by NICE after a rapid review of guidance published earlier in the year. The drug Regorafenib (also called Stivarga and made by Bayer) can now be offered to people with advanced liver cancer if their liver is [...]

By |2018-12-05T09:53:43+00:00December 5th, 2018|Regional News|0 Comments

FDA Approves First Treatment for Lambert-Eaton Myasthenic Syndrome

The US Food and Drug Administration recently approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder that affects the connection between nerves and muscles, and causes weakness and other symptoms in affected patients. This is the first FDA approval of a treatment for LEMS. [...]

By |2018-12-05T09:51:53+00:00December 5th, 2018|Regional News|0 Comments

Researchers Find Promise in New Treatment for Peanut Allergy

Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine have said that an oral immunotherapy drug they tested could be the first FDA-approved medication of its kind for people with peanut allergy. The medication, called AR101, is derived [...]

By |2018-11-21T13:41:37+00:00November 21st, 2018|Regional News|0 Comments

New Approaches for Treating Psychiatric Disorders

Cardiff University has formed a drug discovery collaboration with Takeda Pharmaceutical Company Limited (Takeda) to identify new approaches for treating schizophrenia and other psychiatric disorders. The collaboration will combine the university’s large-scale genomic data, and world-class expertise in psychiatric genetics, genomics, and neuroscience, with Takeda’s extensive drug discovery and clinical development capabilities. ‘Recent developments in [...]

By |2018-11-21T13:40:27+00:00November 21st, 2018|Regional News|0 Comments